Geeplus vs Covid-19: Geeplus Continues to Boost Production of Crucial Ventilator Parts

Beckenham, UK / South Carolina, USA - As countries throughout the world work to coordinate administration of various Covid-19 vaccines, Geeplus' expanded production personnel have continued to work around the clock to support the world's top ventilator manufacturers with crucial actuation devices — most notably, our renowned Voice Coil Motors.


The pandemic created an unprecedented demand for a number of Geeplus products—specifically high-precision voice coil motors and solenoids used in ICU ventilator applications. This led to 24-hour production during the height of the pandemic.


The VM38 voice coil motor in particular is an extremely advanced and highly controllable voice coil actuator, that has aided Geeplus in becoming the world's leading supplier of actuators in medical ventilator applications. Learn more in this brief video.

Geeplus Expands; TRIPLES Production Capacity

Demand has remained high for our high-precision actuators. In response, we've doubled the size of our UK manufacturing facility in London. Production capacity has now tripled!


Now, with the majority of production components created and tested in-house, Geeplus is confident that all of our worldwide customers, across a wide range of industries, will benefit from the extended facility!

To request a quote or learn more about your options for an actuator, visit our Request for Quote (RFQ) Form or “Ask an Engineer” page.

Geeplus is a worldwide leader in the design and manufacture of precision electromechanical actuators. You can find Geeplus online at www.geeplus.com, as well as on social media on LinkedIn, Facebook, and YouTube.

Go to article: Home | What’s next for wearables?Go to article: In this issueGo to article: ContentsGo to article: Formacoat Company InsightGo to article: FormacoatGo to article: BioInteractions Company Insight Go to article: BioInteractions Go to article: BriefingGo to article: Industry newsGo to article: Covid-19 executive briefing by GlobalDataGo to article: The medical industry briefingGo to article: Repsol Company Insight Go to article: Repsol Go to article: Lenzing Plastics Company InsightGo to article: Lenzing PlasticsGo to article: device25Go to article: CommentGo to article: IVD companies seek M&As to avoid Covid cliffGo to article: The CGM-led diabetes market revolution post-Covid-19 outbreakGo to article: Novel solutions to tackle backlog of delayed proceduresGo to article: Sandvik Company InsightGo to article: Sandvik Go to article: Duke Empirical Company Insight Go to article: Duke EmpiricalGo to article: In DepthGo to article: How will Europe’s new device regulations affect medical software?Go to article: The next phase for medical wearablesGo to article: How to future-proof the NHS supply chainGo to article: IUB Ballerine: an ergonomic approach to non-hormonal contraceptionGo to article: Creating connections with Within3Go to article: A womb with a view: the ethical dilemma of ectogenesisGo to article: Gee PlusGo to article: ElectroCraft Company InsightGo to article: ElectroCraftGo to article: GS SwissGo to article: In DataGo to article: Deals analysisGo to article: The medical industry key listGo to article: Global markets and indicesGo to article:  Macro-economic indicatorsGo to article: Macro-economic indicators (page 2)Go to article: CoherentGo to article: On Line ControlsGo to article: Biesterfeld Go to article: EventsGo to article: Next Issue